Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS)
- PMID: 19497611
- DOI: 10.1016/j.thromres.2009.04.022
Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS)
Abstract
Background: Despite venous thromboembolism (VTE) being a major cause of morbidity and mortality, there is still limited information on its prevalence and incidence in the general population.
Objective: To evaluate risk factors, distribution and epidemiology of VTE in the Malmö area with 280,000 inhabitants.
Methods: Patients diagnosed with VTE at Malmö University Hospital in 1998-2006 were invited to a prospective population-based study. Blood sampling and a questionnaire study could be performed in 70% of patients. Remaining 30% were excluded due to language problems, dementia, other severe disease, or unwillingness to participate.
Results: During 1998-2006 1140 VTE patients (559 men [49%, age 62+/-16 years] and 581 women [51%, age 61+/-20 years]) were included. Deep venous thrombosis (DVT) occurred in 882 (77%), pulmonary embolism (PE) in 330 (29%), and both DVT and PE in 72 (6%). The most common acquired risk factors among VTE patients were hormone therapy (24% of female DVT patients and 19% of female PE patients), immobilisation (17% of DVT patients and 18% of PE patients), previous surgery (13% of DVT patients and 19% of PE patients), and concomitant malignant disease (12% of DVT patients and 11% of PE patients). A positive family history for VTE was obtained from 25% of DVT patients and 22% of PE patients. Yearly incidences of VTE, DVT and PE in Malmö were 66, 51, and 19/100.000, respectively.
Conclusion: Hormone therapy, immobilisation, previous surgery and concomitant malignancy were the most common acquired risk factors among VTE patients in this population-based study. The VTE-incidence was lower than in earlier epidemiological studies.
Similar articles
-
Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.Clin Appl Thromb Hemost. 2009 May-Jun;15(3):289-96. doi: 10.1177/1076029608315168. Epub 2008 Apr 8. Clin Appl Thromb Hemost. 2009. PMID: 18400764
-
Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study.Eur J Intern Med. 2010 Aug;21(4):268-72. doi: 10.1016/j.ejim.2010.03.013. Epub 2010 Apr 28. Eur J Intern Med. 2010. PMID: 20603033
-
Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry.Thromb Res. 2008;121(6):751-6. doi: 10.1016/j.thromres.2007.08.009. Epub 2007 Oct 24. Thromb Res. 2008. PMID: 17920107
-
Diagnosis and initial treatment of venous thromboembolism in patients with cancer.J Clin Oncol. 2009 Oct 10;27(29):4889-94. doi: 10.1200/JCO.2009.23.5788. Epub 2009 Sep 8. J Clin Oncol. 2009. PMID: 19738109 Review.
-
Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.Clin Ther. 2007 Nov;29(11):2395-405. doi: 10.1016/j.clinthera.2007.11.015. Clin Ther. 2007. PMID: 18158080 Review.
Cited by
-
Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model.J Thromb Thrombolysis. 2019 Feb;47(2):216-226. doi: 10.1007/s11239-018-1762-7. J Thromb Thrombolysis. 2019. PMID: 30368761 Free PMC article.
-
Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients.Gene. 2018 Mar 20;647:136-142. doi: 10.1016/j.gene.2018.01.013. Epub 2018 Jan 9. Gene. 2018. PMID: 29325734 Free PMC article.
-
[Venous thromboembolic disease in the region of Sidi Bel Abbes, Algeria: frequency and risk factors].Pan Afr Med J. 2013 Oct 10;16:45. doi: 10.11604/pamj.2013.16.45.2620. eCollection 2013. Pan Afr Med J. 2013. PMID: 24648858 Free PMC article. French.
-
Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans.Genome Med. 2017 Nov 24;9(1):98. doi: 10.1186/s13073-017-0495-0. Genome Med. 2017. PMID: 29178968 Free PMC article.
-
Clinical implications of different risk factor profiles in patients with mesenteric venous thrombosis and systemic venous thromboembolism: a population-based study.J Thromb Thrombolysis. 2019 May;47(4):572-577. doi: 10.1007/s11239-019-01816-x. J Thromb Thrombolysis. 2019. PMID: 30756343 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources